Key result
Acute oestrogen improves systolic performance and lowers vascular resistance in men with advanced CHF.
Why the study?
Does acute oestrogen infusion improve haemodynamics in male patients with advanced chronic heart failure?
Does acute oestrogen infusion improve haemodynamics in male patients with advanced chronic heart failure?
Acute oestrogen administration improves indices of cardiac systolic performance and decreases pulmonary and systemic vascular resistance in men with advanced heart failure.
Answers are grounded in this paper and cite their sources.
May warrant randomized trials of acute oestrogen in advanced HF; leaves open any clinical role.
BACKGROUND: Although there are many studies concerning the effects of long-term oestrogen administration on systemic haemodynamics in postmenopausal women, the effects of oestrogen in patients with chronic heart failure are not defined. AIM: The goal of this study was to evaluate the acute haemodynamic effects of oestrogen in male patients with chronic heart failure. METHODS AND RESULTS: We studied 15 men with advanced heart failure (NYHA II-IV, EF < 35%). A Swan-Ganz thermodilution catheter was advanced in their pulmonary artery and central haemodynamics were assessed at baseline, after placebo administration, and following 0.625 and 1.25 mg of oestrogen infusion. Simultaneously, all patients underwent limb plethysmography. Analysis of variance with repeated measures was used to compare the sequential measurements. Following oestrogen administration, right atrial, pulmonary artery and pulmonary capillary wedge pressures, as well as systemic, pulmonary and forearm vascular resistance were decreased; cardiac output, cardiac index, stroke volume, stroke volume index, stroke work index and forearm blood flow were increased. CONCLUSIONS: In male patients with chronic heart failure, acute oestrogen administration improves the indices of cardiac systolic performance and decreases pulmonary and systemic vascular resistance. These findings imply a beneficial effect of oestrogen in selected patients with chronic heart failure.
No takes yet. Share an insight, caveat, or question.
Adamopoulos et al. (2002) studied chronic heart failure (n=15). Oestrogen vs. Baseline and placebo was evaluated on Central haemodynamics and limb plethysmography. Acute oestrogen administration in men with advanced chronic heart failure improved cardiac systolic performance and decreased pulmonary and systemic vascular resistance.
Synapse has enriched 10 related papers. Consider them for comparative context: